Results 251 to 260 of about 662,761 (307)
Some of the next articles are maybe not open access.

Endothelin antagonists

The Lancet, 1999
The very potent endogenous vasoconstrictor endothelin was discovered in 1988. We know now that there are three isoforms (1, 2, and 3) and two receptor subtypes (A and B). A whole range of peptide and non-peptide antagonists has been developed, some selective for A or B receptors and others with non-selective A/B antagonistic activity.
A, Benigni, G, Remuzzi
openaire   +2 more sources

Antagonists of Vitamin A

1966
Publisher Summary Vitamin K activity is shared by a fairly large number of compounds. They consist, in the main, of two naturally occurring groups of compounds: phylloquinones (K), containing saturated isoprenoid side chains, and menaquinones (MK) with unsaturated isoprenoid side chains.
openaire   +3 more sources

CCR1 antagonists

Molecular Diversity, 2008
CCR1 (CC Chemokine receptor 1) is a widely studied G protein-coupled receptor target expressed on multiple types of leukocytes. It is implicated in initiating and exacerbating inflammatory conditions and thus is viewed as a good target for autoimmune and inflammatory therapeutic applications. Numerous CCR1 antagonists have been reported.
Jie-Fei, Cheng, Rick, Jack
openaire   +2 more sources

Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology Into Clinical Utility

Chemical Reviews, 2008
Mojgan Aghazadeh Tabrizi   +2 more
exaly  

Cholecystokinin Antagonists

Annual Review of Pharmacology and Toxicology, 1991
G N, Woodruff, J, Hughes
openaire   +2 more sources

Home - About - Disclaimer - Privacy